Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 2 art units • 2 examiners • 0 of 5 (0%) have an AI response strategy ready
BASF Corporation has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are handled by 2 distinct examiners and are located within 2 distinct art units. MYKOLA V KOVALENKO is the busiest examiner for this portfolio, currently managing 3 pending office actions. This indicates that a majority of the pending workload is assigned to a single individual, while the remaining workload is with the other distinct examiner.
The alignment of 4 pending actions across 2 distinct art units and 2 distinct examiners suggests a consolidated prosecution environment. Because MYKOLA V KOVALENKO oversees 3 pending office actions, his examination style will heavily influence the overall progress of the portfolio. The 2 distinct art units involved indicate that the biotechnology matters are likely categorized into specific sub-fields. With only 2 distinct examiners to engage, the company can maintain a focused communication strategy for its 4 pending office actions in the Biotechnology & Pharmaceuticals technology area.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| Double-patenting only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOVALENKO, MYKOLA V | 4 | 69.5% | +25.8% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18695023 | IMAZAMOX AND GLYPHOSATE FOR CONTROLLING DIGITARIA INSULARIS | SCOTLAND, REBECCA LYNN | 5d |
| 14978281 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15156671 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | 34d |
| 14978281 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | — |
| 13393784 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | — |
| 13393744 | Herbicide-Tolerant Plants | KOVALENKO, MYKOLA V | — |
| Art Unit | Apps |
|---|---|
| 1662 | 4 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695023 | IMAZAMOX AND GLYPHOSATE FOR CONTROLLING DIGITARIA INSULARIS | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | 5d | Pending | Mar 25, 2024 |
| 15156671 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | 1662 | DP | Final Rejection | 34d | Pending | May 17, 2016 |
| 14978281 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | 1662 | §103§112 | Final Rejection | — | Pending | Dec 22, 2015 |
| 13393784 | HERBICIDE-TOLERANT PLANTS | KOVALENKO, MYKOLA V | 1662 | Other | Non-Final OA | — | Pending | Jul 20, 2012 |
| 13393744 | Herbicide-Tolerant Plants | KOVALENKO, MYKOLA V | 1662 | §103 | Final Rejection | — | Pending | Jul 20, 2012 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial